In this Expert Analysis, Roy F. Chemaly, MD, and Guenther Koehne, MD, PhD, discuss key studies presented at the recent Hematology and BMT Tandem meetings on managing CMV infection in patients undergoing bone marrow transplantation.
In this interactive, CME-certified video module, Guenther Koehne, MD, PhD, and Genovefa A. Papanicolaou, MD, provide expert perspectives on current and emerging strategies for managing CMV infection in patients undergoing bone marrow transplantation.
In this downloadable slideset, Guenther Koehne, MD, PhD, and Genovefa A. Papanicolaou, MD, review current and emerging strategies for managing CMV infection in patients undergoing bone marrow transplant.
In multivariate analysis, CMV reactivation predicted by steroid use, CMV reactivation protection by high T-cell response to CMV-specific antigen pp65.
Six-month survival significantly improved in patients with complete or partial virologic response vs stable or progressive disease.
Letermovir prophylaxis also associated with lower all-cause mortality through post-HSCT Week 24 vs placebo.
In this downloadable slideset, expert faculty members Roy F. Chemaly, MD, and Guenther Koehne, MD, PhD, review key studies presented at the Hematology 2016 and 2017 BMT Tandem meetings on managing cytomegalovirus infection in the post–bone marrow transplant setting.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.